Unresectable Gallbladder Carcinoma: Clinical Trials

2 trials for Unresectable Gallbladder Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 2

Follow Unresectable Gallbladder Carcinoma: new trials by email Literature Review of Unresectable Gallbladder Carcinoma trials Research Report on Unresectable Gallbladder Carcinoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
Durvalumab, Guadecitabine - Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type
Phase 1Active not recruitingUniversity of Southern California552018-02-072026-06-01
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
Cisplatin, Docetaxel, Gemcitabine Hydrochloride - Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 1Active not recruitingUniversity of Southern California612015-09-032026-04-29

Narrower conditions

Gallbladder Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cholangiocarcinoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Biliary Tract Diseases (2)  ·  Biliary Tract Neoplasms (2)  ·  Carcinoma (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Gallbladder Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Pancreatic Diseases (2)  ·  Adenocarcinoma (1)  ·  Bronchial Neoplasms (1)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (1)  ·  130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Cisplatin (1)  ·  Docetaxel (1)  ·  Gemcitabine (1)  ·  Platinum (1)  ·  Taxes (1)  ·  durvalumab (1)  ·  guadecitabine (1)

Sponsors

University of Southern California (2)

Countries

United States (2)

Top investigators

Anthony El-Khoueiry (1)  ·  Anthony El-Khoueiry, MD (1)

NIH funding

P30CA014089 (2)